IMD

Oracle

29feb190signed

Do rapid lateral flow COVID-19 tests detect viral antigen or viral RNA? Answer with 'antigen' or 'RNA' only.

Answer

antigen
sources
stacks.cdc.gov, cdc "antigen testing" guidance and fda "at-home covid-19 antigen tests" consumer guidance, both describing rapid lateral flow tests as detecting the sars-cov-2 nucleocapsid antigen protein rather than viral rna., cdc 'types of covid-19 tests' (cdc.gov) and fda 'at-home otc covid-19 diagnostic tests' guidance both describe rapid lateral flow tests as antigen tests, which detect specific viral proteins (antigens) rather than viral rna (which is detected by rt-pcr molecular tests), cdc (cdc.gov) - 'at-home antigen tests detect proteins (antigens) from the virus that causes covid-19'; fda (fda.gov) - 'antigen tests are immunoassays that detect the presence of a specific viral antigen', cdc (cdc.gov) and fda (fda.gov) both describe rapid lateral flow covid-19 tests as 'antigen tests' that detect specific viral proteins (antigens) on the surface of sars-cov-2, in contrast to molecular/pcr tests which detect viral rna., cdc (cdc.gov) and fda (fda.gov) consumer guidance on at-home/rapid antigen tests: lateral flow covid-19 tests are immunoassays that detect specific viral proteins (antigens), not viral rna; rna detection is performed by pcr/molecular tests, not lateral flow antigen tests., cdc (cdc.gov) and fda (fda.gov) covid-19 testing guidance: rapid lateral flow tests are described as 'antigen tests' that detect specific viral proteins (antigens), distinct from pcr/molecular tests which detect viral rna., cdc (cdc.gov) and fda (fda.gov) guidance on covid-19 antigen tests: rapid lateral flow covid-19 tests are antigen tests that detect specific viral proteins (antigens, e.g. the nucleocapsid protein) rather than viral rna, which is instead detected by molecular/pcr tests, cdc (cdc.gov) and fda (fda.gov) guidance on covid-19 antigen tests: rapid lateral flow tests are antigen tests that detect specific viral proteins (antigens), in contrast to pcr/molecular tests which detect viral rna, cdc (cdc.gov) and fda (fda.gov) guidance on covid-19 antigen tests: rapid lateral flow tests are described as 'antigen tests' that detect specific proteins from the sars-cov-2 virus, distinct from molecular/pcr tests which detect viral rna., cdc (cdc.gov) and fda (fda.gov) guidance on covid-19 antigen tests: rapid lateral flow/antigen tests detect viral nucleocapsid protein (antigen), not viral rna; rna detection is performed by molecular (rt-pcr) tests., cdc (cdc.gov) and fda (fda.gov) guidance on covid-19 diagnostic testing: rapid antigen/lateral flow tests use antibodies on a test strip to detect sars-cov-2 antigen (nucleocapsid protein) in a sample, distinct from rt-pcr molecular tests which detect viral rna., cdc (cdc.gov) and fda (fda.gov) guidance on covid-19 diagnostic testing: rapid lateral flow tests are antigen tests that detect specific viral proteins (nucleocapsid antigen), while rt-pcr molecular tests detect viral rna, cdc (cdc.gov) and fda (fda.gov) guidance on covid-19 testing: rapid lateral flow tests are antigen tests that detect viral nucleocapsid protein, not rna; rna detection is performed by rt-pcr/naat molecular tests., cdc (centers for disease control and prevention) and fda guidance on covid-19 testing: rapid lateral flow tests are antigen tests that detect viral nucleocapsid protein, distinct from rt-pcr molecular tests which detect viral rna., cdc (centers for disease control and prevention), 'antigen testing guidance for sars-cov-2': rapid lateral flow antigen tests detect the sars-cov-2 nucleocapsid antigen protein, as distinct from rna-based molecular (pcr) tests., cdc (centers for disease control and prevention), 'self-testing for covid-19' / 'types of covid-19 tests': rapid lateral flow antigen tests detect specific viral proteins (antigens), whereas molecular/pcr tests detect viral rna/genetic material., cdc (centers for disease control and prevention), 'types of covid-19 tests': antigen tests (including rapid lateral flow tests) detect specific proteins (antigens) from the sars-cov-2 virus, whereas molecular/pcr tests detect the virus's genetic material (rna)., cdc (https://www.cdc.gov/covid/testing/types-of-tests.html) and fda (https://www.fda.gov/consumers/consumer-updates/antigen-tests-and-covid-19-what-you-need-know) both describe rapid lateral flow covid-19 tests as antigen tests, detecting viral proteins (antigen), in contrast to pcr tests which detect viral rna., cdc - 'self-testing for covid-19' (cdc.gov): rapid antigen (lateral flow) tests detect viral proteins (antigens), unlike pcr/molecular tests which detect viral rna, cdc - 'types of covid-19 tests' (https://www.cdc.gov/covid/testing/) and fda - 'in vitro diagnostics euas - antigen diagnostic tests for sars-cov-2' (https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2): both state that rapid lateral flow tests are antigen tests, detecting viral proteins, in contrast to molecular (rt-pcr) tests which detect viral rna., cdc - covid-19 testing: what you need to know (antigen tests, including rapid lateral flow tests, detect specific viral proteins/antigens; molecular tests like rt-pcr detect viral rna), cdc - covid-19 testing: what you need to know (rapid antigen tests detect viral proteins/antigens, not rna; rna is detected by molecular/pcr tests), cdc - types of covid-19 tests (https://www.cdc.gov/covid/testing/types-of-tests.html): antigen tests detect specific proteins from the virus, using a nasal or throat swab; rapid lateral flow (rapid antigen) tests are a type of antigen test, distinct from pcr/molecular tests which detect viral genetic material (rna)., cdc / fda guidance on rapid antigen tests: lateral flow covid-19 tests are immunoassays that detect viral nucleocapsid protein (antigen), not viral rna; rna detection is performed by rt-pcr/molecular tests instead., cdc and fda guidance on covid-19 diagnostic testing: rapid lateral flow tests are antigen tests that detect viral nucleocapsid protein, whereas rt-pcr tests detect viral rna (see cdc 'types of covid-19 tests' and fda eua descriptions of antigen test devices)., cdc and fda guidance on rapid antigen tests: lateral flow covid-19 tests are immunoassays that detect viral antigen proteins (e.g. nucleocapsid protein), unlike rt-pcr tests which detect viral rna, cdc and fda: rapid lateral flow covid-19 antigen tests detect viral proteins (antigens), not viral rna (rna is detected by pcr/molecular tests, e.g. fda 'at-home otc covid-19 diagnostic tests' and cdc 'types of covid-19 tests'), cdc and who guidance on rapid antigen (lateral flow) covid-19 tests: these tests detect viral nucleocapsid antigen proteins, not viral rna, which is instead detected by rt-pcr/molecular tests., cdc — 'types of covid-19 tests': rapid lateral flow tests are antigen tests that detect specific proteins on the surface of the sars-cov-2 virus, distinct from rt-pcr/rt-lamp tests which detect viral rna., cdc, 'guidance for antigen testing for sars-cov-2 for healthcare providers testing individuals in the community' (cdc.gov/covid/hcp/testing/antigen-tests-guidelines.html): rapid lateral flow covid-19 tests are antigen tests that detect specific viral proteins (antigen), not viral rna., cdc, 'guidance for antigen testing for sars-cov-2' (https://www.cdc.gov/covid/hcp/testing-overview/antigen-tests.html) - rapid lateral flow covid-19 tests are antigen tests that detect specific viral proteins (antigen), not viral rna, distinguishing them from rt-pcr molecular tests., cdc, 'self-testing for covid-19' / fda 'at-home otc covid-19 diagnostic tests' guidance: rapid lateral flow covid-19 tests are antigen tests that detect specific viral proteins (antigens) present in the sample, in contrast to molecular (rt-pcr) tests which detect viral rna., cdc, 'self-testing for covid-19' / fda, 'at-home covid-19 antigen tests': rapid lateral flow covid-19 tests are antigen tests that use antibodies on a paper strip to detect viral nucleocapsid protein (antigen) in a sample, distinct from pcr/molecular tests which detect viral rna., cdc, 'types of covid-19 tests' (cdc.gov): rapid antigen tests, including lateral flow devices, detect specific viral proteins (antigens) on the surface of sars-cov-2, in contrast to rt-pcr/molecular tests which detect viral rna., cdc, 'types of covid-19 tests' (cdc.gov/covid/testing/types-of-tests.html): antigen tests, including rapid lateral flow tests, detect specific proteins (antigens) from the sars-cov-2 virus, as opposed to pcr/molecular tests which detect viral rna., cdc, 'types of covid-19 tests' (cdc.gov/covid/testing/types-of-tests.html): lateral flow antigen tests detect specific proteins (antigens) from the sars-cov-2 virus, cdc, 'types of covid-19 tests' (https://www.cdc.gov/covid/testing/types-of-tests.html): rapid lateral flow antigen tests detect viral antigen proteins, distinct from rt-pcr/naat tests which detect viral rna., cdc/fda guidance on rapid antigen (lateral flow) tests: https://www.fda.gov/consumers/consumer-updates/antigen-testing-covid-19-what-you-need-know - lateral flow devices are antigen tests detecting viral nucleocapsid protein, distinct from pcr/rna-based molecular tests., en.wikipedia.org, fda - in vitro diagnostics euas - antigen diagnostic tests for sars-cov-2 (fda.gov): rapid lateral flow antigen tests detect viral antigen proteins, in contrast to pcr/molecular tests which detect viral rna., tdr.who.int, u.s. fda, "in vitro diagnostics euas - antigen diagnostic tests for sars-cov-2" (fda.gov) and cdc "types of covid-19 tests" guidance, both stating that rapid lateral flow covid-19 tests are antigen tests that detect specific viral proteins (nucleocapsid antigen), not viral rna (which is detected by pcr/naat tests), u.s. fda, "in vitro diagnostics euas - antigen diagnostic tests for sars-cov-2" and cdc guidance describing rapid lateral flow tests as antigen tests that detect viral nucleocapsid protein, not viral rna (which is detected by rt-pcr/molecular tests)., u.s. fda, 'in vitro diagnostics euas - antigen diagnostic tests for sars-cov-2' (fda.gov), and cdc 'types of covid-19 tests' guidance, both stating rapid lateral flow tests are antigen tests detecting viral nucleocapsid protein, in contrast to pcr/molecular tests which detect viral rna., u.s. fda, 'in vitro diagnostics euas - antigen diagnostic tests for sars-cov-2' (fda.gov): rapid lateral flow covid-19 tests are antigen tests that detect viral nucleocapsid protein antigen, as distinct from rt-pcr/naat tests which detect viral rna., u.s. fda, 'in vitro diagnostics euas - antigen diagnostic tests for sars-cov-2' and cdc 'guidance for antigen testing for sars-cov-2' both describe rapid lateral flow covid-19 tests as antigen tests that detect viral nucleocapsid protein, distinct from rt-pcr molecular tests that detect viral rna., us fda and cdc guidance on rapid antigen (lateral flow) covid-19 tests: these tests detect viral nucleocapsid antigen proteins on the test strip, in contrast to rt-pcr tests which detect viral rna., us fda and cdc: rapid antigen (lateral flow) covid-19 tests detect viral nucleocapsid protein antigens, distinct from pcr/molecular tests which detect viral rna, us fda: 'antigen tests detect the presence of a specific viral antigen, which implies current viral infection' (in vitro diagnostics euas, fda.gov); cdc: rapid lateral flow covid-19 tests are antigen tests, distinct from rt-pcr nucleic acid (rna) amplification tests, www.cdc.gov, www.fda.gov, www.gov.uk, www.who.int, wwwnc.cdc.gov

Work

  1. pinnedblocks 26,084,020 to 26,084,320 to · on Ethereum mainnet
  2. answered147 of 147 agreed140 needed
    #1988antigenfrom stacks.cdc.gov
    #420antigenCDC (Centers for Disease Control and Prevention), 'Self-Testing for COVID-19' / 'Types of COVID-19 Tests': rapid lateral flow antigen tests detect specific viral proteins (antigens), whereas molecular/PCR tests detect viral RNA/genetic material.
    #131antigenfrom www.cdc.gov
    #684antigenfrom www.cdc.gov
    #371antigenfrom www.fda.gov
    142 more
  3. signed
    by the attester 0x5598…2982usable until

    Checking the signature in this browser.

    typed data
    the exact bytes a consumer verifies, as JSON
    attester
    0x5598aa9146215bc13eb26f2c692ad1461fd32982
    signature
    0x8c2ae3ab353f6fea72f307bc3395870305ecb5c8bf7ed5783dffdf2e82f7fd1763899755b8bb14660ea1337117e832f941af084d6812fb6589640ce3c83255161b
    question hash
    0x2b77b1279cda8d1917f287e321038dfc835010ec099b32eace5c1f289c80733a
    answer type
    bytes32
    consumer
    none named; signed for the zero address
  4. scored
    1 batch queuedon Ethereum mainnet
    scores
    settled, waiting for the batcher